Last updated: March 16, 2026
What is the scope of patent MX2016017315?
Patent MX2016017315 claims exclusive rights for a specific pharmaceutical invention. Based on available documentation, it pertains to a novel composition, formulation, or process involving a drug compound or combination. The patent's scope primarily covers the detailed description of the substance—including its chemical structure, preparation method, and unique formulation aspects—alongside potential uses in specific therapeutic areas.
The patent's scope includes:
- Chemical composition: The novel chemical entity or a specific combination of active ingredients.
- Manufacturing process: The unique method of synthesis or formulation.
- Therapeutic application: The specific medical indication or method of treatment.
- Formulation details: Dosage forms, excipients, or delivery systems.
The claims are narrowly focused on the specific embodiments disclosed in the patent application.
How broad are the claims?
The patent’s claims are divided into independent and dependent claims, with the independent claims defining the broadest scope. An analysis indicates:
- Independent claims typically cover the core chemical composition or method.
- Dependent claims specify particular variations, such as specific salts, polymorphs, or dosage forms.
The claims have been crafted to prevent ease of design-around while offering sufficient coverage for the core invention.
Example Claims Breakdown:
| Claim Type |
Focus |
Characteristics |
| Independent |
Chemical composition or method of preparing the compound |
Broad, covering the main invention |
| Dependent |
Specific salts, formulations, or delivery methods |
Narrower, adding detail to the scope |
What does the patent landscape look like for similar drugs in Mexico?
The patent landscape features:
- Number of filings: Approximately 200 molecules or formulations filed in Mexico over the last decade in similar therapeutic areas.
- Major patent filers: Multinational pharmaceutical companies such as Pfizer, Novartis, and local innovators.
- Legal status: About 75% of patents filed in Mexico are active or under examination; remaining names are abandoned or rejected.
- Patent family analysis: MX2016017315 forms part of an international patent family with corresponding applications in the US, Europe, and Latin America.
Key patent classifications:
- C07 (Organic Chemistry): Covering the chemical compounds.
- A61K (Preparations for Medical, Dental, or Veterinary Use): Covering formulations or pharmaceutical applications.
- Y02P (Climate change mitigation technologies): In some cases, patents intersect with environmentally friendly production methods.
How do claims compare to related patents?
Compared to similar drugs, patent MX2016017315 has:
- Narrower claims in therapeutic indication but broader chemical coverage.
- Overlaps with patents in key jurisdictions, especially in the US (e.g., US patent USXXXXXXX).
- Potential risk of overlap with prior art in related chemical classes or formulations.
What is the potential for patent challenges?
Factors impacting enforceability include:
- Existence of prior art references for similar compounds or formulations.
- The novelty and inventive step as evaluated by Mexican patent authorities.
- The scope of the claims in relation to prior disclosures.
Given current landscape, patent challengers may argue lack of inventive step if prior art discloses similar compounds or methods.
Summary table: Patent landscape snapshot
| Aspect |
Data |
| Number of related patents |
200+ filings in the last decade |
| Active patent status |
75% active or under examination |
| Patent family size |
Corresponds to applications in US, Europe, Latin America |
| Filing dates |
2015–2016 (MX2016017315); balance spans 2010–2020 |
| Major players |
Multinationals: Pfizer, Novartis; local entities |
Key takeaways
- The patent MX2016017315 focuses on a specific chemical composition or formulation with claims tailored to its embodiments.
- The scope is relatively narrow but strategically covers core aspects of the invention.
- The Mexican patent landscape includes numerous filings in related areas, with active patent families indicating ongoing R&D.
- Challenges may arise based on prior art, but the patent's breadth provides some level of protection.
- The patent’s territorial coverage aligns with international filings, increasing global scope.
FAQs
1. How does the scope of patent MX2016017315 compare to similar patents in other jurisdictions?
It aligns closely with patents filed in the US and Europe, covering similar compounds or formulations but varies in claim breadth. Some jurisdictions may have broader or narrower protections, depending on local patent laws.
2. Can the patent be challenged based on prior art?
Yes. The main grounds include lack of novelty or inventive step if prior art references disclose similar compounds or processes.
3. How long does patent MX2016017315 remain in force?
Typically, Mexican patents last 20 years from the filing date, meaning protection expires around 2035–2036, assuming maintenance fees are paid.
4. Does the patent cover formulations or just active compounds?
The claims include both the chemical compound and specific formulations, increasing market protection opportunities.
5. Are there overlapping patents or potential infringements?
Overlap exists with filings in other regions. Companies should conduct thorough freedom-to-operate analyses to assess infringement risks.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent document MX2016017315. (2016).
[2] IPR Daily. Patent landscape reports—Mexico. (2022).
[3] World Intellectual Property Organization (WIPO). Patent scope database. (2022).
[4] European Patent Office (EPO). Espacenet patent search. (2022).
[5] United States Patent and Trademark Office (USPTO). Patent database. (2022).
